Table 2.
CCR2 inhibitior (μg/ml) | Vol A | Vol B | Vol C | Vol D | Average | Stdev | %CV |
555.560 | 96.50 | 95.48 | 95.49 | 95.16 | 95.66 | 0.58 | 0.61 |
185.187 | 95.51 | 95.44 | 94.25 | 94.53 | 94.93 | 0.64 | 0.67 |
61.729 | 92.82 | 92.76 | 92.64 | 93.63 | 92.96 | 0.45 | 0.49 |
20.576 | 90.89 | 91.16 | 90.10 | 90.00 | 90.54 | 0.58 | 0.64 |
6.859 | 84.82 | 86.28 | 85.47 | 86.23 | 85.70 | 0.69 | 0.81 |
2.286 | 78.30 | 76.71 | 81.54 | 79.55 | 79.03 | 2.04 | 2.58 |
0.762 | 71.21 | 75.22 | 71.71 | 69.85 | 72.00 | 2.29 | 3.18 |
0.254 | 59.49 | 67.06 | 62.80 | 59.43 | 62.20 | 3.61 | 5.80 |
0.085 | 43.23 | 57.00 | 49.56 | 47.31 | 49.28 | 5.78 | 11.73 |
0.028 | 31.18 | 38.57 | 36.08 | 35.06 | 35.22 | 3.07 | 8.72 |
0.009 | 23.76 | 24.64 | 21.35 | 24.84 | 23.65 | 1.60 | 6.77 |
0.005 | 13.81 | 15.68 | 11.31 | 13.44 | 13.56 | 1.79 | 13.22 |
Based on MESF values